ADIAL PHARMACEUTICALS, INC. (ADIL)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Dec. 15, 2025 | CORRESP | Neutral/Informational | Moderate | Adial Pharmaceuticals, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-3, which was filed on December … | Read Filing EDGAR |
| Jun. 12, 2025 | CORRESP | Neutral/Informational | Moderate | Adial Pharmaceuticals, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1, originally filed on June 6, 2025. They… | Read Filing EDGAR |
| Jun. 12, 2025 | CORRESP | Neutral/Informational | Low | Adial Pharmaceuticals, Inc. has formally withdrawn its request for the acceleration of the effectiveness of its Registration Statement on Form S-1, which was initially filed on Ju… | Read Filing EDGAR |
| Jun. 6, 2025 | CORRESP | Neutral/Informational | Moderate | Adial Pharmaceuticals, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1 to June 10, 2025. This request indicate… | Read Filing EDGAR |
| Jun. 5, 2025 | CORRESP | Neutral/Informational | Moderate | Adial Pharmaceuticals, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3, originally filed on May 30, 2025. They… | Read Filing EDGAR |
| Jun. 4, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Adial Pharmaceuticals, Inc. that it will not review their registration statement filed on May 30, 2025. The letter emphasizes the company's responsibil… | Read Filing EDGAR |